Selective toxicity and enhanced therapeutic index of liposomal polyene antibiotics in systemic fungal infections.

PubWeight™: 1.00‹?› | Rank: Top 15%

🔗 View Article (PMID 3860162)

Published in Ann N Y Acad Sci on January 01, 1985

Authors

R L Juliano, G Lopez-Berestein, R Hopfer, R Mehta, K Mehta, K Mills

Articles by these authors

A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta (1976) 7.41

Signal transduction by integrins: increased protein tyrosine phosphorylation caused by clustering of beta 1 integrins. Proc Natl Acad Sci U S A (1991) 5.76

Cell adhesion or integrin clustering increases phosphorylation of a focal adhesion-associated tyrosine kinase. J Biol Chem (1992) 4.33

Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolates. Antimicrob Agents Chemother (1995) 4.27

Integrin-mediated cell adhesion activates mitogen-activated protein kinases. J Biol Chem (1994) 4.27

Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin B. J Infect Dis (1983) 3.86

Accelerated aging and nucleolar fragmentation in yeast sgs1 mutants. Science (1997) 3.48

Redistribution of silencing proteins from telomeres to the nucleolus is associated with extension of life span in S. cerevisiae. Cell (1997) 3.44

Integrin signaling and cell growth control. Curr Opin Cell Biol (1998) 3.32

Selective inhibition of fibronectin-mediated cell adhesion by monoclonal antibodies to a cell-surface glycoprotein. Science (1985) 3.24

Signal transduction and signal modulation by cell adhesion receptors: the role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins. Pharmacol Rev (1998) 3.05

The South London Somatisation Study. I: Longitudinal course and the influence of early life experiences. Br J Psychiatry (1993) 2.80

Efficacy and safety of once-daily umeclidinium/vilanterol 62.5/25 mcg in COPD. Respir Med (2013) 2.75

Leukemic phase of mantle cell lymphoma two case reports and review of the literature. Arch Pathol Lab Med (1996) 2.66

Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study. J Infect Dis (1985) 2.64

Biopsy of the prostate guided by transrectal ultrasound: relation between warfarin use and incidence of bleeding complications. Clin Radiol (2005) 2.39

Regulation of anchorage-dependent signal transduction by protein kinase A and p21-activated kinase. Nat Cell Biol (2000) 2.37

Autoimmune aetiology for acquired neuromyotonia (Isaacs' syndrome) Lancet (1991) 2.28

A strategy for the reduction of childhood injuries in Massachusetts: SCIPP. N Engl J Med (1982) 2.27

Cognitive effects of lamotrigine compared with topiramate in patients with epilepsy. Neurology (2006) 2.24

Liposomal amphotericin B is toxic to fungal cells but not to mammalian cells. Biochim Biophys Acta (1984) 2.21

New spectrum of fungal infections in patients with cancer. Rev Infect Dis (1989) 2.16

Testing of Mycobacterium tuberculosis susceptibility to ethambutol, isoniazid, rifampin, and streptomycin by using Etest. J Clin Microbiol (1996) 2.09

Bacteremia caused by Campylobacter-like organisms in two male homosexuals. Ann Intern Med (1984) 2.07

The alpha v beta 1 integrin functions as a fibronectin receptor but does not support fibronectin matrix assembly and cell migration on fibronectin. J Cell Biol (1993) 2.06

Systemic candidiasis in cancer patients. Am J Med (1984) 2.05

Apparent diffusion coefficient histogram analysis stratifies progression-free survival in newly diagnosed bevacizumab-treated glioblastoma. AJNR Am J Neuroradiol (2011) 2.00

Isolation and characterization of Chinese hamster ovary cell variants deficient in the expression of fibronectin receptor. J Cell Biol (1989) 1.95

Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia (2006) 1.88

Increased tumorigenicity of fibronectin receptor deficient Chinese hamster ovary cell variants. Cancer Res (1991) 1.86

Treatment of hepatosplenic candidiasis with liposomal-amphotericin B. J Clin Oncol (1987) 1.83

The effect of particle size and charge on the clearance rates of liposomes and liposome encapsulated drugs. Biochem Biophys Res Commun (1975) 1.78

Integrin-mediated activation of MAP kinase is independent of FAK: evidence for dual integrin signaling pathways in fibroblasts. J Cell Biol (1997) 1.78

Cell anchorage permits efficient signal transduction between ras and its downstream kinases. J Biol Chem (1997) 1.75

Evaluation of Etest method for determining caspofungin (MK-0991) susceptibilities of 726 clinical isolates of Candida species. J Clin Microbiol (2001) 1.74

Altered tissue distribution of amphotericin B by liposomal encapsulation: comparison of normal mice to mice infected with Candida albicans. Cancer Drug Deliv (1984) 1.74

Cell adhesion molecules, signal transduction and cell growth. Curr Opin Cell Biol (1999) 1.73

Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: a phase I clinical trial. J Clin Oncol (2001) 1.73

Tissue transglutaminase expression promotes cell attachment, invasion and survival in breast cancer cells. Oncogene (2006) 1.72

Motility of fibronectin receptor-deficient cells on fibronectin and vitronectin: collaborative interactions among integrins. J Cell Biol (1992) 1.67

Liposome-encapsulated amphotericin B for treatment of disseminated candidiasis in neutropenic mice. J Infect Dis (1984) 1.67

Treatment of systemic fungal infections with liposomal amphotericin B. Arch Intern Med (1989) 1.64

Phorbol ester modulation of integrin-mediated cell adhesion: a postreceptor event. J Cell Biol (1989) 1.63

Integrin alpha 5 beta 1 expression negatively regulates cell growth: reversal by attachment to fibronectin. Mol Biol Cell (1995) 1.60

In vitro antifungal activities of amphotericin B and liposome-encapsulated amphotericin B. Antimicrob Agents Chemother (1984) 1.58

Evaluation of the Etest method for determining voriconazole susceptibilities of 312 clinical isolates of Candida species by using three different agar media. J Clin Microbiol (2000) 1.58

First-line therapy with moderate dose capecitabine in metastatic breast cancer is safe and active: results of the MONICA trial. Eur J Cancer (2010) 1.57

Comparison of four commercially available rapid enzyme immunoassays with cytotoxin assay for detection of Clostridium difficile toxin(s) from stool specimens. J Clin Microbiol (1994) 1.56

The emerging role of Fusarium infections in patients with cancer. Medicine (Baltimore) (1988) 1.56

Integrin-mediated adhesion regulates ERK nuclear translocation and phosphorylation of Elk-1. J Cell Biol (2001) 1.54

Human CD38: a glycoprotein in search of a function. Immunol Today (1994) 1.53

Aging in Saccharomyces cerevisiae. Annu Rev Microbiol (1998) 1.52

Mechanism of the selective toxicity of amphotericin B incorporated into liposomes. Mol Pharmacol (1987) 1.51

Integrin-mediated activation of MEK and mitogen-activated protein kinase is independent of Ras [corrected]. J Biol Chem (1996) 1.50

Anchorage-dependent ERK signaling--mechanisms and consequences. Curr Opin Genet Dev (2002) 1.50

The alpha 5 beta 1 integrin fibronectin receptor, but not the alpha 5 cytoplasmic domain, functions in an early and essential step in fibronectin matrix assembly. J Biol Chem (1993) 1.49

Evaluation of Etest method for determining posaconazole MICs for 314 clinical isolates of Candida species. J Clin Microbiol (2001) 1.48

Need for alternative trial designs and evaluation strategies for therapeutic studies of invasive mycoses. Clin Infect Dis (2001) 1.48

Biological approaches to the controlled delivery of drugs: a critical review. Pharmacol Rev (1984) 1.47

Integrin and cytoskeletal regulation of growth factor signaling to the MAP kinase pathway. J Cell Sci (1999) 1.47

Pharmacokinetics, tissue distribution, and toxicity of free and liposomal amphotericin B in diabetic rats. J Infect Dis (1990) 1.46

In vitro model of angiogenesis using a human endothelium-derived permanent cell line: contributions of induced gene expression, G-proteins, and integrins. J Cell Physiol (1992) 1.46

An essential role for the caspase dronc in developmentally programmed cell death in Drosophila. J Biol Chem (2000) 1.46

Stability of antisense DNA oligodeoxynucleotide analogs in cellular extracts and sera. Life Sci (1991) 1.46

Expression and function of a putative cell surface receptor for fibronectin in hamster and human cell lines. J Cell Biol (1986) 1.46

Lipid emulsion: is there sufficient knowledge among hospital staff? Anaesthesia (2010) 1.45

In vitro susceptibility testing of filamentous fungi: comparison of Etest and reference microdilution methods for determining itraconazole MICs. J Clin Microbiol (2000) 1.44

Integrin-mediated tyrosine phosphorylation and cytokine message induction in monocytic cells. A possible signaling role for the Syk tyrosine kinase. J Biol Chem (1995) 1.44

Immune reactions in human filariasis. J Clin Microbiol (1978) 1.43

Effects of sterols on the therapeutic efficacy of liposomal amphotericin B in murine candidiasis. Cancer Drug Deliv (1983) 1.43

Nutritional support after liver transplantation: a randomized prospective study. JPEN J Parenter Enteral Nutr (1990) 1.43

Acute dialysis quality initiative (ADQI). Nephrol Dial Transplant (2001) 1.42

Molecular mechanisms of yeast aging. Trends Biochem Sci (1998) 1.42

Human CD38: a (r)evolutionary story of enzymes and receptors. Leuk Res (2001) 1.41

Liposomal delivery of methylphosphonate antisense oligodeoxynucleotides in chronic myelogenous leukemia. Blood (1994) 1.41

The efficacy of topical corneal anesthesia with 0.5% bupivacaine eyedrops. Can J Ophthalmol (1995) 1.40

Aspergillus epiglottitis. Cancer (1983) 1.39

alpha5beta1 integrin protects intestinal epithelial cells from apoptosis through a phosphatidylinositol 3-kinase and protein kinase B-dependent pathway. Mol Biol Cell (2000) 1.39

Definition of an unexpected ligand recognition motif for alphav beta6 integrin. J Biol Chem (1999) 1.38